High Baseline Patient's Compared with Evaluator's Global Assessment Is Associated with Lower Retention and Remission Rates of First TNF Inhibitor in Psoriatic Arthritis Patients - Data from the EuroSpA Research Collaboration Network

dc.contributor.authorMichelsen, Brigitte
dc.contributor.authorOrnbjerg, Lykke Midtboll
dc.contributor.authorMann, Herman
dc.contributor.authorKvien, Tore
dc.contributor.authorNissen, Michael J.
dc.contributor.authorSantos, Maria Jose
dc.contributor.authorHetland, Merete Lund
dc.date.accessioned2026-08-12T18:12:58Z
dc.date.issued2019
dc.departmentFırat Üniversitesi
dc.descriptionAnnual Meeting of the American-College-of-Rheumatology/Association-of-Rheumatology-Professionals (ACR/ARP) -- NOV 08-13, 2019 -- Atlanta, GA
dc.description.abstract[Abstract Not Available]
dc.description.sponsorshipAmer Coll Rheumatol,Assoc Rheumatol Profess
dc.identifier.issn2326-5191
dc.identifier.issn2326-5205
dc.identifier.urihttps://hdl.handle.net/11508/64146
dc.identifier.volume71
dc.identifier.wosWOS:000507466901258
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWeb of Science
dc.language.isoen
dc.publisherWiley
dc.relation.ispartofArthritis & Rheumatology
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WoS_20260511
dc.titleHigh Baseline Patient's Compared with Evaluator's Global Assessment Is Associated with Lower Retention and Remission Rates of First TNF Inhibitor in Psoriatic Arthritis Patients - Data from the EuroSpA Research Collaboration Network
dc.typeConference Object

Dosyalar